Eaton-Lambert syndrome is another autoimmune disorder of the neuromuscular junction. The patient's immune system produces antibodies against the calcium channel at the nerve ending of the ...

Please provide your email address to receive an email when new articles are posted on . Patients with nontumor Lambert-Eaton myasthenic syndrome had survival rates comparable to the general population ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved amifampridine tablets for the treatment of adult patients with Lambert-Eaton myasthenic ...

Catalyst Pharmaceutical Partners, Inc. is a specialty pharmaceutical company focused on the development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and ...

For adult and pediatric patients 6 years of age and older weighing at least 45kg, the maximum daily dosage has been increased from 80mg to 100mg. The Food and Drug Administration (FDA) has approved ...

Lambert-Eaton myasthenic syndrome (LEMS) is a rare autoimmune condition that disrupts communication between nerves and muscles, leading to weakness and fatigue. In LEMS, the signal from the nerve ...

Lambert-Eaton myasthenic syndrome (LEMS) is a rare autoimmune condition that disrupts communication between nerves and muscles, leading to weakness that often starts in the hips and legs. In people ...

Patients experiencing isolated dysphagia may be showing early signs of a rare condition called Lambert-Eaton myasthenic syndrome (LEMS), according to a letter to the editor published on March 12 in ...

This week we are going to discuss a topic that we had briefly touched on earlier, the neurologic autoimmune conditions: myasthenia gravis and Lambert Eaton Syndrome (LEMS). To review: Myasthenia ...

Firdapse was previously granted Orphan Drug designation and Breakthrough Therapy designation, as well as Priority Review by the FDA. The Food and Drug Administration (FDA) has approved Firdapse ...

What Tools Were Used in the Studies for Lambert-Eaton Myasthenic Syndrome (LEMS)? Before describing how Firdapse was studied, it is important to understand the tools that were used in the studies.

The FDA has granted approval to the first treatment for children with Lambert-Eaton myasthenic syndrome (LEMS), a rare autoimmune disorder. The drug, amifampridine (Ruzurgi), is approved for the ...